Παρασκευή 30 Μαρτίου 2018

Improvement in the proinsulin/C-peptide ratio during treatment with ipragliflozin in Japanese patients with type 2 diabetes mellitus.

Related Articles

Improvement in the proinsulin/C-peptide ratio during treatment with ipragliflozin in Japanese patients with type 2 diabetes mellitus.

Expert Opin Pharmacother. 2018 Mar 29;:

Authors: Takase T, Nakamura A, Yamamoto C, Atsumi T, Miyoshi H

PMID: 29591723 [PubMed - as supplied by publisher]



https://ift.tt/2pUX8Hw

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου